Lataa...
Interim [(18)F]FDG PET/CT can predict response to anti-PD-1 treatment in metastatic melanoma
PURPOSE: In an attempt to identify biomarkers that can reliably predict long-term outcomes to immunotherapy in metastatic melanoma, we investigated the prognostic role of [(18)F]FDG PET/CT, performed at baseline and early during the course of anti-PD-1 treatment. METHODS: Twenty-five patients with s...
Tallennettuna:
| Julkaisussa: | Eur J Nucl Med Mol Imaging |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Springer Berlin Heidelberg
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8113306/ https://ncbi.nlm.nih.gov/pubmed/33336264 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-020-05137-7 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|